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Abstract: This work introduces a new additive named 4,4’-trimethylenedipiperidine for the practical and ecofriendly
preparation of ethyl 5-amino-7-(4-phenyl)-4,7-dihydro-[1,2,4]triazolo[1,5-a ]pyrimidine-6-carboxylate derivatives. This
chemical is commercially available and easy to handle. It also possesses a low melting point and a broad liquid range
temperature, high thermal stability, and good solubility in water. Based on green chemistry principles, the reaction
was performed in a) a mixture of green solvents i.e. water and ethanol (1:1 v/v) at reflux temperature, and b) the
additive was liquefied at 65 ◦ C and the reaction was conducted in the liquid state of the additive. High yields of
the desired triazolo-pyrimidines were obtained under both aforementioned conditions. Our results demonstrated that
this additive, containing 2 Lewis base sites and able to act as an acceptor-donor hydrogen bonding group, is a novel
and efficient alternative to piperidine, owing to its unique properties such as its reduced toxicity, nonflammable nature,
nonvolatile state, broad liquid range temperature, high thermal stability, and ability to be safely handled. Furthermore,
this additive could be completely recovered and exhibited high recyclability without any change in its chemical structure
and no significant reduction in its activity. The current methodology has several advantages: (a) it avoids the use of
hazardous materials, as well as toxic, volatile, and flammable solvents, (b) it does not entail tedious processes, harsh
conditions, and the multistep preparation of catalysts, (c) it uses a metal-free and noncorrosive catalyst, and (d) reduces
the generation of hazardous waste and simple work-up processes. The most important result of this study is that
4,4’-trimethylenedipiperidine can be a promising alternative for toxic, volatile, and flammable base reagents in organic
synthesis owing to its unique properties.
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1. Introduction
Solvents play a vital role in both academic and industrial research, and they can influence the reaction mechanism
and route, selectivity, reaction rate, type, and yield of a product. Hence, the choice of an appropriate solvent
is a vital issue in organic reactions. An ideal solvent for organic reactions should be commercially available,
costeffective, nontoxic, nonvolatile, biocompatible, biodegradable, recoverable, reusable, and have low risks
associated with its handling and storage; furthermore, a nonflammable solvent with a high flash point and
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selective soluble is preferred. The environmental, technical, and economic issues related to the solvent, how
it is used, and what it is made from are important factors in selecting a sustainable solvent [1]. Ionic liquids
(ILs) have been widely used as solvents and/or catalysts in a variety of organic reactions. The fabrication of
some ionic liquids involves tedious procedures and harsh conditions, the use of toxic and corrosive reagents or
expensive reactants, as well as toxic, flammable, and volatile solvents [2]. To overcome these issues, the design
and development of sustainable solvents that are clean and involve green media is an attractive and promising
area in organic chemistry.
According to the principles of green chemistry, the design and development of new efficient catalysts and
methods require researchers to follow several standards such as (a) using inexpensive, less toxic, nonvolatile
solvents and chemicals for the fabrication of catalysts, for the separation of products and workup, or recovery
of catalysts; (b) using green solvents or conducting reactions under solvent-free conditions, which results
in reducing hazardous waste generation; (c) avoiding toxic and metal-containing catalysts, as well as using
recyclable catalysts which promote reactions by using their catalytic amount [3,4].
Triazolo[1,5-a]pyrimidines (TPs) display a broad range of pharmaceutical and medicinal properties [5–
8]. Various substituted triazolo[1,5-a ]pyrimidines have been prepared through a one-pot, three-component
condensation of active methylene compounds, aminotriazoles, and aldehydes using different catalytic systems
[6]. The developed methods have certain drawbacks, along with several advantages. There are very often two
or more preparative steps for the fabrication of the catalysts, which can raise the cost and may involve the use
of toxic and volatile solvents. Some other methods require a tedious work-up, together with the washing and
rinsing the products or catalysts multiple times, which leads to the generation of toxic and hazardous wastes.
Hence, there is a high demand for the development of metal-free protocols, which employ nontoxic solvents,
along with easily separable and recyclable catalysts.
Very recently, a series of novel 1,2,4-triazolo[1,5-a ]pyrimidines were prepared using ionic liquid and
porous organic polymer [9,10]. Based on the unique properties of 4,4’-trimethylenedipiperidine (TMDP) and
its successful catalytic applications in some organic synthesis [11–13], we were encouraged to investigate the
potential of TMDP as a catalyst or dual solvent-catalyst for the preparation of 1,2,4-triazolo[1,5-a ]pyrimidines
through a one-pot three-component reaction.
2. Results and discussion
2.1. Synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives in the presence of TMDP as catalyst
or dual solvent-catalyst
Initially, the condensation of 3 model reactants, including 4-chlorobenzaldehyde (1a), 3-amino-1,2,4-triazole,
and ethyl cyanoacetate was investigated in different conditions to find the optimal conditions (Table 1). The
equimolar model reactants were stirred together in the water as a green solvent at room temperature or reflux
condition for 2 h in the absence of a catalyst (Table 1, entries 1 and 2). A large amount of the unreacted
4-chlorobenzaldehyde (1a) was detected together with a few spots on the TLC at reflux temperature, and
only substrates were detected at room temperature. The addition of a catalytic amount of TMDP caused a
remarkable rise in the yield of 2a under reflux conditions (Table 1, entries 3 and 4). Regarding the limited
solubility of substrates in water, the next experiments were conducted in a mixture solvent of water and ethanol
(50:50% v/v), which lead to an improvement of the yield of 2a (Table 1, entry 5). The amount of TMDP
was then increased two-fold, which caused a negligible rise in the yield of 2a Table 1, entry 6). These results
1101
GHAFFARI KHALIGH et al./Turk J Chem
demonstrate that this three-component reaction required a catalyst and higher temperature due to its high
activation energy.
Table 1. Optimization of different parameters including TMDP loading, temperature, and stirring time for the model
reaction.a
Entry Amount of TMDP (mg) Solvent Temp. (◦C) Time (min) Yield (%)b
1 - H2O r.t. 120 -
2 - H2O Reflux 120 A few spots
3 40 H2O r.t. 120 32
4 40 H2O Reflux 120 70
5 40 H2O/EtOH (1:1 v/v) Reflux 120 91
6 80 H2O/EtOH (1:1 v/v) Reflux 120 92
7 500 Liquefied TMDP 65 120 92
8 500 Liquefied TMDP 65 60 92
9 500 Liquefied TMDP 65 40 77
aReaction conditions: 4-chlorobenzaldehyde (285.0 mg, ∼2.0 mmol), ethyl cyanoacetate (244 µL, 2.0 mmol), 3-amino-1,2,4-triazole
(168 mg, 2.0 mmol), solvent (2 mL).
bYields after trituration of the reaction mixture in water and recrystallization from ethanol.
In our previous work, it was observed that TMDP has a low melting point (52.3 ◦C) and a high boiling
point (332.5 ◦C) [13]. Hence, TMDP has a wider liquid range (∼280 ◦C) than water and ethanol. Furthermore,
TMDP has 2 Lewis base sites, and it can simultaneously act as both a hydrogen bond acceptor and donor. In
the next experiments, we conducted the model reaction at 65 ◦C, and TMDP changed into its molten state;
the mixture of reactants was easily stirred in the liquefied TMDP (Table 1, entries 7–9). The highest yield was
observed for a length of time lasting approximately 60 min (Table 1, entry 8).
We chose entries 6 and 8 in Table 1 as the optimal conditions and investigated the scope and generality
of the current protocols (Scheme 1).
Benzaldehydes bearing electron-withdrawing and electron-donating substituents smoothly incorporated
the corresponding triazolo[1,5-a ]pyrimidines under both optimized reaction conditions. The results in Table
2 show that the effect of nature and the position of substituents in the yields and rates are negligible within
the experimental error. Nevertheless, benzaldehydes bearing electron-donating groups produced lower yields
after longer reaction times in comparison with electron-withdrawing substituents in the same positions (Table 2,
entries 1–6,10). Moreover, the para-substituted benzaldehydes bearing the electron-donating groups exhibited
lower yields than the electron-withdrawing substituents (Table 2, entries 3,5,10). Also, ortho-substituted
benzaldehydes resulted in higher yields than the same substituents at the para-positions (Table 2, entries
3,5 vs. 4,6). All known products showed a melting point and 1H NMR and 13C NMR consistent with
previous reports in the literature [9]. The 1H NMR and 13C NMR of 5-amino-7-(4-phenyl)-4,7-dihydro-
[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate esters 2(a–j), together with their copies, can be found in Appendix
A (see Supplementary Material).
The model reaction was also carried out using 20 µL (∼10 mol%) and 40 µL (∼20 mol%) of piperidine
under optimized conditions in 2.0 mL of ethanol/H2O, which resulted in the desired product at 32% and 73%
yields, respectively. In another experiment, 2.0 mmol of model reactants were added into 0.5 g of piperidine and
stirred at 65 ◦C for 60 min, which gave 2a at a 86% yield. Although the 2 reagents, TMDP and piperidine, can
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Scheme 1. Preparation of ethyl 5-amino-7-(4-phenyl)-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-
carboxylates using (a) molten-state TMDP (b) a solution of TMDP in a mixture of solvents ethanol/water
(1:1 v/v).
be interchanged under the appropriate conditions, TMDP is preferred because of the high toxicity and unsafe
handling of piperidine. Besides, there is limited piperidine availability in some institutions and/or countries due
to its use as a substrate for illegal, psychotropic drugs. This can therefore cause administrative problems when
purchasing piperidine [14].
Very recently, Jonnalagadda et al. fabricated a heterogeneous catalyst viz. the bismuth loaded on
fluorapatite (Bi2O3 /FAp), which was used for the preparation of 1,2,4-triazolo[1,5-a ]pyrimidine scaffolds in
ethanol at room temperature [15]. Despite high yields of the products (92–96%) within 25–35 min using 30
mg catalyst per 1 mmol benzaldehyde derivatives, the fabrication of the catalyst has drawbacks; for example,
(a) there is a mixture of metal-contained Lewis acids in the catalyst composition, in which each salt can play
a role in promoting the reaction, while the effect of the different cations and anions were not clarified and
investigated; (b) high energy-consuming procedure due to high temperature for a long time and centrifugation;
(c) the catalyst was rinsed several times with water during the catalyst preparation, which can lead to generating
hazardous waste via leakage of cations and anions. Furthermore, Lewis acids are not traditional catalysts for the
preparation of pharmaceutical and medicine products due to their high toxicity [16]. Also, it is well known that
aldehydes bearing substituents such as methoxy, nitro-, cyano-, or heterocycle aldehydes containing nitrogen or
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Table 2. The preparation of ethyl 5-amino-7-(4-phenyl)-4,7-dihydro-[1,2,4]triazolo[1,5-a ]pyrimidine-6-carboxylates us-
ing TMDP as a catalyst or catalyst/solvent, respectively, under 2 optimized reaction conditions.a
Entry 1(a–j) 2(a–j) Method Ab Method Bc Melting point (◦C)
Time (min) Yield (%)d Time (min) Yield (%)d Found Reported [9]
1 4-Cl-C6H4- 2a 60 92 120 92 190–191 190–191
2 4-Br-C6H4- 2b 60 90 120 87 181–183 184–185
3 4-NO2-C6H4- 2c 60 93 100 91 196–198 197–198
4 2-NO2-C6H4- 2d 70 86 140 81 180–182 183–184
5 4-(CH3O)-C6H4- 2e 85 87 140 84 188–189 187–188
6 2-(CH3O)-C6H4- 2f 85 81 120 76 202–203 205–206
7 3,4-(CH3O)-C6H3- 2g 80 83 120 79 189–190 190–191
8 2,4,6-(CH3O)3-C6H2- 2h 85 80 150 76 206–207 206–207
9 3,4,5-(CH3O)3-C6H2- 2i 80 80 120 76 210–212 211–212
10 4-(CH3)2N-C6H4- 2j 85 80 180 73 181–182 181–182
aReaction conditions: various substituted benzaldehydes 1(a–j) (0.5 mmol), ethyl cyanoacetate (61 µL, 0.5 mmol); 3-amino-1,2,4-triazole (42 mg, 0.5 mmol).
bMolten state of TMDP (125 mg); reaction temperature (65 ◦C).
c10 mol% of TMDP (10.5 mg, 0.05 mmol); a mixture of ethanol and water (0.5 mL, 1:1 v/v) at reflux temperature.
dIsolated yield.
sulphur atoms, and coordinating solvents such as water can deactivate Lewis acids by the coordination of their
acidic sites [17,18]. Moreover, most Lewis acids require an activation step before application. All the above
results show that the catalytic efficiency of TMDP is an efficient, safe, and ecofriendly catalyst for the synthesis
of 1,2,4-triazolo[1,5-a ]pyrimidines.
According to the mechanism of the Knoevenagel reaction in the literature, 2 possible mechanisms are
illustrated in Scheme 2 [19,20]. Based on reaction mechanism A, the ethyl cyanoacetate and aldehyde are
activated through hydrogen bonding and the Lewis base property of TMDP. The ethyl cyanoacetate attacks
the activated benzaldehyde, which gives the intermediate (I). The dehydration of intermediate (I) gives the
Knoevenagel intermediate (II). The B route involves the iminium intermediate (IV), which acts as the acceptor
of the enol of ethyl cyanoacetate and gives the corresponding Knoevenagel product. After this, in the A and B
routes, TMDP can activate 3-amino-1,2,4-triazole, followed by a the reaction with the Knoevenagel intermediate
(II), which gives the intermediate (III). Then, the intermediate (III) produces the triazolo[1,5-a ]pyrimidine
through an intramolecular cyclization.
Finally, the condensation of model reactants was carried out on a large scale as an industrial application.
A flask fitted with a mechanical stirrer was charged with 12.50 g of TMDP and heated up to 65 ◦C. Then, 7.24
g of 4-chlorobenzaldehyde and 4.42 g of 3-amino-1,2,4-triazole, as well as 5.43 mL of ethyl cyanoacetate (5.428
mL) were slowly added to the liquefied TMDP with continuous stirring. After 1 h, 15 mL of deionized water
was added to the mixture, and the white solid was filtered on a Büchner funnel and rinsed 3 times with 5 mL of
deionized water. The purification of the crude product was conducted by recrystallization from the hot ethanol
(20 mL), which gave 13.11 g of 2a (82%). After removing the water from the filtrate, the recovered TMDP was
reused for the mmole scale reactions.
2.2. Easy separation and recyclability of TMDP
The separation of TMDP and the crude products was conducted through the trituration of the reaction mixture
in water and subsequent filtration. TMDP was recovered through solvent removal by a rotary evaporator in a
vacuum. The results demonstrated that the recovered TMDP could be reused for 10 subsequent runs, which
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Scheme 2. The possible schematic reaction mechanisms.
enabled 2a reach a range of 92–82% isolated yield. Although a 5.6-wt. % loss of TMDP was detected during
10 runs during the recovering process, 1H NMR analysis of retrieved TMDP showed no detectable changes in
the chemical structure of TMDP after the 10th run (Figure). The leaching of TMDP onto the product was also
investigated by an LC-MS analysis of 2a, which showed a negligible amount of TMDP after each run.
3. Conclusion
TMDP was employed to catalyze a one-pot three-component reaction in its molten-state as a dual solvent-
catalyst under mild conditions. The preparation of 1,2,4-triazolo[1,5-a]pyrimidine derivatives demonstrated the
efficiency of TMDP as a high recyclable additive and dual solvent catalyst. The advantages of the current
methodologies are (a) they are metal-free and mild conditions; (b) there is high yield within short reaction
times; (c) there is a simple separation of the catalyst or solvent/catalyst and desired products; (d) there is
minimal generation of hazardous wastes. The unique features of TMDP, such as the fact that it is commercially
available, that it has a wide liquid range, that is bears Lewis base sites and hydrogen bond acceptor-donor
groups, and that it has high recyclability, make it a promising catalyst for organic synthesis. In addition,
TMDP can be a safe alternative for toxic, flammable, and volatile organic base catalysts.
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1
H NMR of TMDP fresh 
 
1
H NMR of TMDP after 10
th
 run 
Figure 1. 1 H NMR of TMDP fresh (up) and 1 H NMR of TMDP after 10 th run (down).
1106
GHAFFARI KHALIGH et al./Turk J Chem
4. Experimental
4.1. General
All chemicals were supplied by Merck, Aldrich, and Fluka chemical companies and used as purchased. The
TLC and silica gel SIL G/UV 254 plates were employed to determine the purity of substrates and for reaction
monitoring. The samples were charged into open capillary tubes, and their melting point was measured on
a Büchi B-545 apparatus. A Bruker Avance 400 MHz instrument was used to record the 1H and 13C NMR
spectra. Microanalyses were performed on a Perkin-Elmer 240-B microanalyzer.
4.2. Typical procedure for the preparation of ethyl 5-amino-7-(4-chlorophenyl)-4,7-dihydro-[1,2,4]
triazolo[1,5-a]pyrimidine-6-carboxylate (2a) using TMDP as a catalyst in mixture of water
and ethanol (1:1 v/v)
A mixture of 4-chlorobenzaldehyde (285.0 mg, 2.0 mmol), 3-amino-1,2,4-triazole (168 mg, 2.0 mmol), ethyl
cyanoacetate (244 µL, 2.0 mmol), and TMPD (40 mg, ∼10 mol%) was stirred in water/ethanol (2.0 mL, 1:1
v/v) for an appropriate time at reflux conditions. After completion of the reaction (monitored by TLC), the
solvent was removed with a rotary evaporator under reduced pressure. Then 1.0 mL of water was added with
a dropping tube, the suspension was thoroughly mixed by a stirring rod, and the additive and product were
separated by simple filtration. The white solid was rinsed with a few drops of water (20 drops), which gave
612.0 mg of crude product (∼95%). The crude product was dissolved in 1.0 mL of ethanol at 50 ◦C, which
produced 580.0 mg of pure product (∼92%) after cooling to room temperature overnight. After the addition
of an appropriate amount of ethanol to the aqueous solution of TMDP, it was reused in the next run without
any washing, drying, or purification.
4.3. Typical procedure for the synthesis of ethyl 5-amino-7-(4-chlorophenyl)-4,7-dihydro-[1,2,4]
triazolo[1,5-a]pyrimidine-6-carboxylate (2a) using TMDP as dual solvent-catalyst in the
molten-state
The mixture of 4-chlorobenzaldehyde (285.0 mg, 2.0 mmol), 3-amino-1,2,4-triazole (168 mg, 2.0 mmol), and
ethyl cyanoacetate (244 µL, 2.0 mmol) was stirred in TMPD (0.5 g) at 65 ◦C. After completion of the reaction
(monitored by TLC), the deionized water (0.5 mL) was added to the reaction mixture. The crude product and
additive were separated by simple filtration. The crude product was purified by recrystallization from ethanol
by the same above-mentioned procedure, which gave 583 mg of white powder (∼92%). The solvent was removed
from the aqueous solution of TMDP under reduced pressure with a rotary evaporator, and the recovered TMDP
was reused in the next runs without any rinsing, drying, or purification.
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Supplementary material
1HNMR and 13C NMR of 2(a–j) (NMR spectra were recorded in a 400 MHz Bruker instrument, and DMSO-d6
was used as an NMR solvent).
2a)
1H NMR δ8.83 (s, 2H, NH2) , 8.41 (s, 1H, triazole-CH), 8.07 (d, J = 8.6 Hz, 2H, Ar-H), 7.66 (d, J
= 8.6 Hz, 2H, Ar-H), 6.56 (s, 1H, NH), 5.65 (s, 1H, CH), 4.31 (q, J = 7.2 Hz, 2H, –(C=O)OCH2CH3) ,
1.30 (t, J = 7.2 Hz, 3H, –(C=O)OCH2CH3) ppm; 13C NMR (100 MHz, DMSO-d6) δ 161.6 (C=O), 153.6
(triazole-C), 143.1 (C5), 138.0 (triazole-CH), 132.4 (C-2’ and C-6’), 130.2 (C-1’), 129.4 (C-3’ and C-5’), 115.4
(C-4’), 103.2 (C-6), 62.44 (–(C=O)OCH2CH3) , 51.7 (C-7), 14.0 (–(C=O)OCH2CH3) ppm; Anal. Calcd. For
C14H14ClN5O2 : C, 52.59; H, 4.41; N, 21.90; Found: C, 52.57; H, 4.45; N, 21.87.
2b)
1H NMR δ 8.68 (s, 2H, NH2) , 8.42 (s, 1H, triazole-CH), 7.98 (d, J = 8.6 Hz, 2H, Ar-H), 7.81 (d,
J = 8.6 Hz, 2H, Ar-H), 6.43 (s, 1H, NH), 5.63 (s, 1H, CH), 4.36 (q, J = 7.2 Hz, 2H, –(C=O)OCH2CH3) ,
1.30 (t, J = 7.2 Hz, 3H, –(C=O)OCH2CH3) ppm; 13C NMR (100 MHz, DMSO-d6) δ 161.6 (C=O), 153.8
(triazole-C), 140.0 (C5), 132.5 (C-2’ and C-6’), 132.4 (C-3’ and C-5’), 130.5 (triazole-CH), 127.1 (C-1’), 115.4
(C-4’), 103.4 (C-6), 62.4 (–(C=O)OCH2CH3) , 52.0 (C-7), 14.0 (–(C=O)OCH2CH3) ppm; Anal. Calcd. For
C14H14BrN5O2 : C, 46.17; H, 3.87; N, 19.23; Found: C, 46.14; H, 3.91; N, 19.21.
2c)
1H NMR δ 8.85 (s, 1H, triazole-CH), 8.53 (s, 2H, NH2) , 8.04 (d, J = 8.2 Hz, 2H, Ar-H), 7.63 (d, J =
8.2 Hz, 2H, Ar-H), 6.61 (s, 1H, NH), 5.64 (s, 1H, CH), 4.34 (q, J = 7.2 Hz, 2H, –(C=O)OCH2CH3) , 1.34 (t, J
= 7.2 Hz, 3H, –(C=O)OCH2CH3) ppm; 13C NMR (100 MHz, DMSO-d6) δ 163.6 (C=O), 152.9 (triazole-C),
143.2 (C5), 139.2 (triazole-CH), 132.5 (C-2’ and C-6’), 130.5 (C-3’ and C-5’), 128.2 (C-1’), 115.3 (C-4’), 103.2
(C-6), 62.3 (–(C=O)OCH2CH3) , 51.8 (C-7), 14.0 (–(C=O)OCH2CH3) ppm; Anal. calcd. for C14H14N6O4 :
C, 50.91; H, 4.27; N, 25.44; Found: C, 50.88; H, 4.32; N, 25.47.
2d)
1H NMR δ 8.83 (s, 1H, triazole-CH), 8.55 (s, 2H, NH2) , 8.32 (d, J = 8.2 Hz, 1H, Ar-H), 7.97-7.91
(m, 2H, Ar-H), 7.84 (t, J = 7.6 Hz, 1H, Ar-H), 6.61 (s, 1H, NH), 5.63 (s, 1H, CH), 4.35 (q, J = 7.0 Hz, 2H,
–(C=O)OCH2CH3) , 1.33 (t, J = 7.0 Hz, 3H, –(C=O)OCH2CH3) ppm; 13C NMR δ 160.9 (C=O), 154.9
(triazole-C), 147.2 (C-2’), 141.2 (C5), 134.7 (triazole-CH), 132.5 (C-6’), 130.5 (C-5’), 128.2 (C-1’), 125.2 (C-4’),
114.2 (C-3’), 107.4 (C6), 62.7 (–(C=O)OCH2CH3) , 52.0 (C-7), 13.9 (–(C=O)OCH2CH3) ppm; Anal. calcd.
for C14H14N6O4 : C, 50.91; H, 4.27; N, 25.44; Found: C, 50.86; H, 4.33; N, 25.41.
2e)
1H NMR (400 MHz, DMSO-d6) δ 8.57 (s, 2H, NH2) , 8.31 (s, 1H, triazole-CH), 8.07 (d, J = 8.8 Hz,
2H, Ar-H), 7.13 (d, J = 8.8 Hz, 2H, Ar-H), 6.43 (s, 1H, NH), 5.22 (s, 1H, CH), 4.28 (q, J = 7.0 Hz, 2H,
–(C=O)OCH2CH3) , 3.85 (s, 3H, –OCH3) , 1.28 (t, J = 7.0 Hz, 3H, –(C=O)OCH2CH3) ppm; 13C NMR (100
MHz, DMSO-d6) δ 163.5 (C=O), 162.3 (C-4’), 154.4 (triazole-C), 137.1 (C5), 133.5 (C-2’ and C-6’), 123.9
(triazole-CH), 116.2 (C-1’), 114.9 (C-3’ and C-5’), 98.5 (C-6), 62.0 (–(C=O)OCH2CH3) , 55.7 (OCH3) , 51.7
(C-7), 14.0 (–(C=O)OCH2CH3) ppm; Anal. calcd. for C15H17N5O3 : C, 57.13; H, 5.43; N, 22.21; Found: C,
57.08; H, 5.47; N, 22.24.
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2f)
1H NMR (400 MHz, DMSO-d6) δ 8.54 (s, 1H, triazole-CH), 8.35 (s, 2H, NH2) , 8.12 (d, J = 7.8 Hz,
1H, Ar-H), 7.64-7.59 (m, 1H, Ar-H), 7.20-7.17 (m, 1H, Ar-H), 7,13-7.09 (m, 1H, Ar-H), 6.37 (s, 1H, NH), 5.65
(s, 1H, CH), 4.30 (q, J = 7.0 Hz, 2H, –(C=O)OCH2CH3) , 3.87 (s, 3H, –OCH3) , 1.29 (t, J = 7.0 Hz, 3H,
–(C=O)OCH2CH3) ppm; 13C NMR (100 MHz, DMSO-d6) δ 161.9 (C=O), 158.8 (C-2’), 148.9 (triazole-
C), 140.6 (C5), 135.5 (C-6’), 128.4 (C-4’), 120.7 (triazole-CH), 119.7 (C-1’), 115.6 (C-5’), 112.1 (C-3’), 102.1
(C-6), 62.3 (–(C=O)OCH2CH3) , 56.0 (OCH3) , 51.7 (C-7), 13.9 (–(C=O)OCH2CH3) ppm; Anal. calcd. for
C15H17N5O3 : C, 57.13; H, 5.43; N, 22.21; Found: C, 57.11; H, 5.45; N, 22.18.
2g)
1H NMR δ8.45 (s, 2H, NH2) , 8.23 (s, 1H, triazole-CH), 7.72 (s, 1H, Ar-H), 7.69 (dd, J = 8.6 and
1.6 Hz, 1H, Ar-H), 7.14 (d, J = 8.4 Hz, 1H, Ar-H), 6.38 (s, 1H, NH), 5.21 (s, 1H, CH), 4.30 (q, J =
7.0 Hz, 2H, –(C=O)OCH2CH3) , 3.88 (s, 3H, –OCH3) , 3.80 (s, 3H, –OCH3) , 1.31 (t, J = 7.0 Hz, 3H, –
(C=O)OCH2CH3) ppm; 13C NMR (100 MHz, DMSO-d6) δ 162.4 (C=O), 154.6 (C-3’), 153.6 (C-4’), 148.8
(triazole-C), 131.1 (C5), 126.8 (triazole-CH), 124.0 (C-1’), 116.3 (C-6’), 113.0 (C-5’), 111.9 (C-2’), 98.6 (C-
6), 62.0 (–(C=O)OCH2CH3) , 56.0 (OCH3) , 55.5 (OCH3) , 52.0 (C-7), 14.0 (–(C=O)OCH2CH3) ppm; Anal.
calcd. for C16H19N5O4 : C, 55.64; H, 5.55; N, 20.28; Found: C, 55.61; H, 5.58; N, 20.24.
2h)
1H NMR δ8.61 (s, 2H, NH2) , 8.26 (s, 1H, triazole-CH), 6.65 (s, 1H, NH), 6.31 (s, 2H, Ar-H), 5.71 (s,
1H, CH), 4.25 (q, J = 7.0 Hz, 2H, –(C=O)OCH2CH3) , 3.86 (s, 3H, –OCH3) , 3.84 (s, 6H, –OCH3) , 1.26
(t, J = 7.0 Hz, 3H, –(C=O)OCH2CH3) ppm; 13C NMR δ 165.8 (C=O), 163.1 (C-4’), 160.8 (C-2’ and C-
6’), 146.7 (triazole-C), 140.0 (C5), 115.6 (triazole-CH), 103.2 (C-3’ and C-5’), 102.1 (C-1’), 91.0 (C-6), 61.8
(–(C=O)OCH2CH3) , 55.8 (OCH3 at the para-position), 55.6 (OCH3 at the ortho-position), 51.4 (C-7), 14.0
(–(C=O)OCH2CH3) ppm; Anal. calcd. for C17H21N5O5 : C, 54.39; H, 5.64; N, 18.66; Found: C, 54.42; H,
5.59; N, 18.61.
2i)
1H NMR δ 8.62 (s, 2H, NH2) , 8.27 (s, 1H, triazole-CH), 6.66 (s, 1H, NH), 6.43 (s, 2H, Ar-H), 5.61
(s, 1H, CH), 4.29 (q, J = 7.0 Hz, 2H, –(C=O)OCH2CH3) , 3.82 (s, 3H, –OCH3) , 3.80 (s, 6H, –OCH3) , 1.28
(t, J = 7.0 Hz, 3H, –(C=O)OCH2CH3) ppm; 13C NMR δ 167.4 (C=O), 165.8 (C-4’), 160.8 (C-3’ and C-
5’), 141.7 (triazole-C), 130.0 (C5), 105.6 (triazole-CH), 103.3 (C-1’), 102.1 (C-2’ and C-6’), 91.0 (C-6), 62.0
(–(C=O)OCH2CH3) , 55.8 (OCH3 at the para-position), 55.6 (OCH3 at the meta-position), 51.4 (C-7), 14.0
(–(C=O)OCH2CH3) ppm; Anal. calcd. for C17H21N5O5 : C, 54.39; H, 5.64; N, 18.66; Found: C, 54.41; H,
5.57; N, 18.69.
2j)
1H NMR δ 8.36 (s, 2H, NH2) 8.06 (s, 1H, triazole-CH), 7.92 (d, J = 9.0 Hz, 2H, Ar-H), 6.81 (d, J = 9.0
Hz, 2H, Ar-H), 6.27 (s, 1H, NH), 5.21 (s, 1H, CH), 4.24 (q, J = 7.0 Hz, 2H, –(C=O)OCH2CH3) , 3.05 (s, 6H,
–N(CH3)2) , 1.25 (t, J = 7.0 Hz, 3H, –(C=O)OCH2CH3) ppm; 13C NMR δ 163.4 (C=O), 154.1 (C-4’), 153.7
(triazole-C), 137.2 (C5), 133.7 (C-2’ and C-6’), 118.3 (triazole-CH), 117.5 (C-1’), 111.6 (C-3’ and C-5’), 92.0
(C-6), 61.4 (–(C=O)OCH2CH3) , 52.6 (C-7), 40.1 (–N(CH3)2) , 14.1 (–(C=O)OCH2CH3) ppm; Anal. calcd.
for C17H21N5O5 : C, 58.52; H, 6.14; N, 25.59; Found: C, 58.48; H, 6.19; N, 25.56.
1H and 13C NMR copies of 2(a–j) were recorded with a 400 MHz Bruker instrument in DMSO-d6 .
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